The use of corticosteroids improved the odds that adults who are critically ill with COVID-19 would survive, according to data from four studies recently published in JAMA.
“This is, in many respects, the single clearest answer we’ve had so far on how to manage terribly ill COVID-19 patients,” Derek Angus, MD, MPH, chair of the critical care medicine department at the University of Pittsburgh and investigator with Randomized Embedded Multifactorial Adaptive Platform-Community Acquired Pneumonia (REMAP-CAP), said in a press release.
WHO is updating its treatment recommendations
Uncategorized